KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Operating Expenses (2016 - 2025)

Historic Operating Expenses for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $54.7 million.

  • LifeMD's Operating Expenses rose 474.36% to $54.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $218.9 million, marking a year-over-year increase of 1423.15%. This contributed to the annual value of $203.0 million for FY2024, which is 3706.82% up from last year.
  • As of Q3 2025, LifeMD's Operating Expenses stood at $54.7 million, which was up 474.36% from $55.7 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Operating Expenses ranged from a high of $55.7 million in Q2 2025 and a low of $26.9 million during Q1 2021
  • Moreover, its 5-year median value for Operating Expenses was $38.4 million (2023), whereas its average is $41.6 million.
  • Examining YoY changes over the last 5 years, LifeMD's Operating Expenses showed a top increase of 47152.28% in 2021 and a maximum decrease of 1397.41% in 2021.
  • Over the past 5 years, LifeMD's Operating Expenses (Quarter) stood at $35.5 million in 2021, then decreased by 3.07% to $34.4 million in 2022, then grew by 21.07% to $41.7 million in 2023, then increased by 29.37% to $53.9 million in 2024, then grew by 1.52% to $54.7 million in 2025.
  • Its Operating Expenses was $54.7 million in Q3 2025, compared to $55.7 million in Q2 2025 and $54.5 million in Q1 2025.